Argentina Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine
Condition:   COVID-19 Vaccine Intervention:   Biological: ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2) Sponsors:   Laboratorio Pablo Cassara S.R.L.;   Universidad Nacional de San Martín (UNSAM);   National Council of Scientific and Technical Research, Argentina Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials